2,4-Dimethoxybenzene-1,3-diol | 3904-12-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 英文名称: 2,4-Dimethoxybenzene-1,3-diol
• 英文别名: hydroxy-2,6-dimethoxyphenol；dimethoxy resorcinol；a-Oxy-syringol
• CAS: 3904-12-9
• 化学式: C₈H₁₀O₄
• 分子量: 170.165
• InChiKey: XPWKQCXQOKBWRC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  58.9
• 氢给体数：
  2
• 氢受体数：
  4

文献信息

• Cannabinoids
  申请人：Martin R. Billy

  公开号：US20050159449A1

  公开（公告）日：2005-07-21

  Compounds of the formula: wherein R, R1 and R4 are defined in the specification, and pharmaceutically acceptable salts, esters and tautomers thereof, having activity at peripheral cannabinoid receptors, commonly designated the CB2 receptor class. The compounds are useful for therapy, especially in the treatment of pain, inflammation and autoimmune disease.

  该化合物的公式为：其中R，R1和R4在说明书中定义，并且其药物可接受的盐，酯和互变异构体，在外周大麻素受体（通常称为CB2受体类）具有活性。该化合物在治疗中非常有用，特别是在疼痛，炎症和自身免疫疾病的治疗中。
• [EN] CANNABINOIDS<br/>[FR] CANNABINOIDES
  申请人：UNIV VIRGINIA COMMONWEALTH

  公开号：WO2003091189A1

  公开（公告）日：2003-11-06

  Compounds of the formula: wherein R, R1 and R4 are defined in the specification, and pharmaceutically acceptable salts, esters and tautomers thereof, having activity at peripheral cannabinoid receptors, commonly designated the CB2 receptor class. The compounds are useful for therapy, especially in the treatment of pain, inflammation and autoimmune disease.

  该公式化合物的其中R、R1和R4在规范中有定义，并且其药用可接受的盐、酯和互变异构体，具有在周围大麻素受体上的活性，通常被称为CB2受体类。这些化合物在治疗中具有用途，尤其是在治疗疼痛、炎症和自身免疫性疾病方面。
• Use and pharmaceutical composition for liver fibrosis prevention and/or treatment
  申请人：Cojet Biotech Inc.

  公开号：US10945991B2

  公开（公告）日：2021-03-16

  The present disclosure discloses an extract of Antrodia cinnamomea and pharmaceutical application thereof. As confirmed by the researches of the present disclosure, said extract of Antrodia cinnamomea is able to decrease the activities of hepatic stellate cell and therefore obtain the efficacy of liver fibrosis prevention and/or treatment. Accordingly, the present disclosure discloses a novel pharmaceutical application of Antrodia cinnamomea and provides an alternative prevention and/or treatment regime of liver fibrosis for the field.

  本公开披露了一种肉桂蕨提取物及其药物应用。 经本公开的研究证实，所述肉桂酚提取物能够降低肝星状细胞的活性，从而获得预防和/或治疗肝纤维化的功效。 因此，本公开披露了一种新型的肉桂蚂蚁药学应用，并为该领域提供了一种可供选择的肝纤维化预防和/或治疗方案。
• Carbogel anode materials and method for their preperation
  申请人：UNIWERSYTET JAGIELLONSKI

  公开号：US11117802B2

  公开（公告）日：2021-09-14

  Carbogel anode materials and method for their preparation are disclosed. The described carbogels exhibit, at a temperature of 20° C., an electrical conductance of at least 0.5 S/cm and a reversible electrochemical capacity in relation to lithium of at least 350 mAh/g under a C/2 discharge current, enabling their use for preparation of anode materials, particularly those intended for preparation of lithium-ion cells.

  本发明公开了碳凝胶正极材料及其制备方法。所述碳凝胶在 20° C 温度下的电导率至少为 0.5 S/cm，在 C/2 放电电流下与锂有关的可逆电化学容量至少为 350 mAh/g，因此可用于制备负极材料，特别是用于制备锂离子电池的负极材料。
• Preparing 7-alkoxybenzofurans and intermediates used therein
  申请人：THE UPJOHN COMPANY

  公开号：EP0094769B1

  公开（公告）日：1986-11-26